Holen Sie sich die Stockscreener-App
14.93
0.20%
0.03
Handel nachbörslich:
15.02
0.09
+0.60%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Axogen Inc Aktie (AXGN) Neueste Nachrichten
Wall Street Analysts Predict a 76.37% Upside in AxoGen (AXGN): Here's What You Should Know - MSN
Will Axogen Inc. outperform its industry peersTrade Risk Assessment & Weekly Breakout Stock Alerts - newsyoung.net
AxoGen’s SWOT analysis: nerve repair innovator’s stock poised for growth By Investing.com - Investing.com Nigeria
Raymond James Slashes PT on Axogen (AXGN) to $20 From $21 - MSN
AxoGen price target lowered to $20 from $21 at Raymond James - MSN
Axogen's Strategic Position in the Evolving Peripheral Nerve Repair Market: A Deep Dive into Clinical Success, Regulatory Momentum, and Growth Potential - AInvest
Axogen: Broad Range Of Outcomes Still Present, Opting To Remain Sidelined - Seeking Alpha
Cantor Fitzgerald reiterates Overweight rating on AxoGen stock after strong Q2 - Investing.com Australia
IBD Rating Upgrades: Axogen Shows Improved Price Strength - Investor's Business Daily
Axogen Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Ichimoku Cloud Indicates Uncertainty Around Axogen Inc.Expert Verified Stock Trade Ideas Backed by Data - beatles.ru
Axogen Inc Reports Strong Q2 2025 Earnings with 18.3% Revenue Growth and BLA Approval Expected in September - AInvest
AxoGen’s Earnings Call: Strong Growth Amid Challenges - The Globe and Mail
Axogen 2025 Q2 Earnings Returns to Profitability with 130.1% Net Income Jump - AInvest
Axogen raises 2025 revenue growth target to at least 17% as BLA approval nears - MSN
AxoGen, Inc. (NASDAQ:AXGN) Q2 2025 Earnings Call Transcript - Insider Monkey
Axogen Reports Strong Q2 2025 Financial Results - The Globe and Mail
AxoGen: Q2 Earnings Snapshot - Stamford Advocate
Axogen Inc (AXGN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements - Investing.com Canada
Axogen, Inc. Reports Strong Revenue Growth in Q2 2025 - TipRanks
Axogen (AXGN) Q2 Revenue Jumps 18% - AOL.com
AxoGen stock price target lowered to $20 by Raymond James on BLA timing - Investing.com Nigeria
Axogen (AXGN.O) Sees Sharp Intraday Move—What's Driving the Volatility? - AInvest
AxoGen reports Q2 adjusted EPS 12c, consensus 6c - TipRanks
AxoGen Q2 2025 Earnings Call Transcript - MarketBeat
Jefferies raises AxoGen stock price target to $25 on strong sales growth - Investing.com India
Jefferies raises AxoGen stock price target to $25 on strong sales growth By Investing.com - Investing.com South Africa
Axogen's Q2 2025 Earnings Call: Unpacking Contradictions in Margins, BLA Milestones, and Growth Strategies - AInvest
Transcript : Axogen, Inc., Q2 2025 Earnings Call, Aug 05, 2025 - MarketScreener
Axogen Boosts 2025 Revenue Growth Target to at Least 17% Ahead of BLA Approval. - AInvest
Axogen, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:AXGN) - Seeking Alpha
Axogen (AXGN.O) Sees Sharp Intraday Spike—What’s Driving the Volatility? - AInvest
AxoGen's Q2 Earnings Exceed Expectations with Strong Financial TurnaroundNews and Statistics - IndexBox
Axogen Stock Soars 18.25% on Strong Q2 Earnings - AInvest
AxoGen (AXGN) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
AxoGen Q2 revenue up 18.3%, beats estimates - MarketScreener
Axogen Inc earnings beat by $0.06, revenue topped estimates - Investing.com Australia
Axogen's Q2 2025 Financial Outlook and Strategic Position in the Peripheral Nerve Repair Market - AInvest
Axogen, Inc. Reports Second Quarter 2025 Financial Results - The Manila Times
AxoGen Q2 2025 Earnings Preview - MSN
Should I hold or sell Axogen Inc. stock in 2025Dynamic portfolio growth - Jammu Links News
Is it the right time to buy Axogen Inc. stockBreakthrough stock performance - Jammu Links News
Is Axogen Inc. a good long term investmentCapitalize on emerging investment opportunities - Jammu Links News
What catalysts could drive Axogen Inc. stock higher in 2025Spectacular growth rates - Jammu Links News
What institutional investors are buying Axogen Inc. stockConsistently high returns - Jammu Links News
1.74%
0.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):